Partner with TruVision
We utilize a holistic approach in the execution of both traditional and decentralized clinical trials.
Minimize Financial Liability with Reliable Results
TruVision Clinical Research Partners provides clear information about pricing and the return on investment (ROI) that sponsors can expect with a focus on the cost implications of under performing clinical trials and low diversity enrollment.
SITE SUPPORT
TruVision Clinical Research Partners has a team of highly experienced senior nurses staff called clinical navigators. Our team of experienced clinical navigators provide on going patient support throughout a trial to its conclusion. TVCRP navigators are keenly focused on social determinants of health (SODH) and will actively work to mitigate the impacts. Our navigators will be made available to your institution to ensure that you have the support necessary to successfully conduct your studies.
-
Implementation
The implementation process includes detailed planning and coordination with the clinical trial team, including site selection, patient recruitment, and training for local healthcare providers.
-
Training & Certification
When necessary TVCRP provides GCP training and certification.
-
Support Services
Continuous support is provided to the PI and patient throughout the trial, including (if necessary) personalized in-home visits, telehealth consultations, and real-time monitoring of patients performing CT tasks.
TruVision Clinical Research Partners has a team of highly experienced senior nurses staff called clinical navigators. Our team of experienced clinical navigators provide on going patient support throughout a trial to its conclusion. TVCRP navigators are keenly focused on social determinants of health (SODH) and will actively work to mitigate the impacts. Our navigators will be made available to your institution to ensure that you have the support necessary to successfully conduct your studies.
-
Implementation
The implementation process includes detailed planning and coordination with the clinical trial team, including site selection, patient recruitment, and training for local healthcare providers.
-
Training & Certification
When necessary TVCRP provides GCP training and certification.
-
Support Services
Continuous support is provided to the patient throughout the trial, including (if necessary) personalized in-home visits, telehealth consultations, and real-time monitoring of patients performing CT tasks.
PATIENT SUPPORT
TVCRP provides comprehensive support services to enhance the likelihood of the success of clinical trials in all domains.
-
Telehealth
Telehealth enhances patient engagement and data accuracy.
-
Support Services
Continuous support is provided to the patients throughout the trial, including (if necessary) personalized in-home visits, telehealth consultations, and real-time monitoring of patients performing CT tasks.
-
Patient Support
TVCRP has access to a Patient Care Center that is the
central hub for remote monitoring of the CT process. -
Questions
For more information about clinical trials, visit www.clinicaltrials.gov.
Our Clinical Research Consortium Accelerates Trials
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
Clinical Research Consortium to Accelerate Trials
Clinical Research Consortium to Accelerate Trials
Our Clinical Research Consortium is a strategic alliance of clinical sites, contract research organizations (CROs), and industry sponsors—working together to transform how clinical trials are designed and executed. With a shared commitment to innovation, speed, and quality, the consortium streamlines operations across the trial lifecycle and ensures a more connected, efficient, and patient-centric research model.
A core pillar of our consortium is our Decentralized Clinical Trial (DCT) capability, which empowers sites and sponsors to reach broader, more diverse patient populations. Through remote monitoring, telemedicine, home health services, and digital data collection, we reduce participant burden, accelerate recruitment, and improve retention—all while maintaining data integrity and regulatory compliance.
- Advanced Ocular Melanoma – Phase 2, multi-country
- Ophthalmology (Device) Myopia Study – Phase 3 Single country
- Ophthalmology (Device) Myopia Post-marketing – Phase 4
- Single Country Ophthalmology Cataract Study – Phase 3 Multi-Country
- Cervical Intraepithelial Neoplasia – Phase 1/2a, multi-country
- Metastatic Squamous Non-small cell Lung Cancer – Phase 3 Multi-country
- Metastatic Non-squamous Non-Small Cell Lung Cancer – Phase 3, multi-country
- Brain metastases from Non-small cell Lung Cancer – Phase 3 Multi-country
- Peripheral T-cell Lymphoma – Phase 2 Single Country
- Breast Cancer/Bone Pain – Phase 2b Multi-Country
- B-Cell Lymphoma – Phase 3 multi country
- Pancreatic Cancer – Phase 3 multi-country
- SARs CoV2 (Covid-19) – Phase 2, single country
- SARS CoV2 (COVID-19) – Observational Study, Single Country
- Influenza Study – Phase 3, single country
Crohn’s Disease – Phase 3 Multi-Country
- Angina – Phase 3, multi country
- Atrial Fibrillation – Pilot Study, Single Center
- Atherosclerosis Study – Phase 2 Multi-Center
- Vertis CV-Diabetes Safety Study – Phase 3 Multi-Center
- Chest Pain Study – Phase 3 Multi-Country
- Hypertension Study – Phase 2 Multi-Country
- Type 1 Diabetes Study – Phase 2, Multi-Country
- Type 2 Diabetes Study – Phase 2, Multi-Country
- Urinary Incontinence – Phase 3 Multi-Country
- Overactive Bladder – Phase 3, multi-country
- Prostate cancer – Phase 1, multi-country
- Abarelix Prostate Cancer Study – Phase 3 Multi-Center
- Vardenafil ED Study – Phase 3 Multi-Center
- Lupron Prostate Cancer Study – Phase 3 Multi-Cente
- Uprima ED Study – Phase 3 Multi-Center
- Vasomax ED Study – Phase 3 Multi-Center
Chronic Kidney disease – Phase 3 multi-country
- Anxiety Disorder – Phase 3 Single Country
- Alzheimer’s Study – Phase 2 Multi-Center
- Bipolar 1 Disorder – Phase 1&2, single-country
- Schizophrenia with Ophthalmology Component – Phase 2 Single Country
- Pain Management – Phase 3 Multi-Country
- Major Depressive Disorder Study – Phase 2 Single Country
- Sickle Cell 1st in Human Study – Phase 1 Multi-Center
- Sickle Cell Study – Phase 1 Multi-Center, Multi-Country
- Sickle Cell Study – Phase 2/3 Multi-Country
- COPD Study – Phase 2/3 Multi-Center
- Gout Study – Phase 3 Multi-Country
- Wound Healing Device Study – Phase 2 Multi-Center
- Antibiotic Coated Penile Prosthesis – Phase 3 Multi-Center
- Urinary Incontinence Device Study – Phase 3 Multi-Center
- MIST BPH Study – Prospective Multi-Center Surgical study
About Us
We are the leader in innovation & execution of comprehensive patient recruitment and
clinical trial management.